Discover the complete record of transactions filed by CRUTCHFIELD BRADFORD, Chief Commercial Officer. Insider active across 1 companies, notably 10x Genomics, Inc.. In total, 31 disclosures have been logged. Total volume traded: €188k. The latest transaction was filed on 23 May 2022 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
25 of 31 declarations
Bradford J. Crutchfield is best known for his role as Chief Commercial Officer at 10x Genomics, Inc., a position he took in February 2017. In that role, he oversaw global sales, marketing, business development, and customer support, helping scale the commercial organization of a leading U.S.-listed genomics company. His background is rooted in a long career in the life sciences tools industry, with more than 30 years of experience in commercial sales, marketing, and technology adoption across academic and pharmaceutical research markets. Prior to joining 10x Genomics, he served as Senior Vice President of the Life Sciences Business Area at QIAGEN, where he led the company’s business across academia, pharma, and applied testing customer segments. He also served as Vice President and General Manager for EMEA at Illumina, giving him broad international leadership experience across Europe, the Middle East, and Africa. Before that, he spent many years at Bio-Rad Laboratories, where he held positions of increasing responsibility and ultimately became Executive Vice President and President of the Life Science Group. This progression reflects a career centered on commercial leadership, market expansion, and the adoption of complex scientific technologies. He also served as a director of NanoString Technologies for a period, indicating broader involvement in the life sciences innovation ecosystem. Overall, Crutchfield’s profile combines deep sector expertise, cross-regional commercial leadership, and experience scaling growth at prominent biotechnology and life science companies.